top of page
Search

A2A Panelist

  • Writer: A2A Pharma
    A2A Pharma
  • May 16, 2019
  • 1 min read

Updated: Feb 7, 2020

A2A Founder & CEO Edward Painter was a panelist at BIO Investor forum panel entitled "Applying artificial intelligence to improve therapy development today"


 
 
 

Recent Posts

See All

Comments


bottom of page